Atlas Trials

T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

Clinical trial NCT00609219 · COMPLETED

Trial details

NCT number
NCT00609219
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2001-08-01
Primary completion
2007-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.